斯皮罗诺拉克启动注册中心随机干预试验心力衰竭与保存的喷射部分 (SPIRRIT-HFpEF):理由和设计
Lars H Lund1,2, Stefan James3, Adam D DeVore4
1Department of Medicine, Karolinska Institutet, Sweden.
European journal of heart failure
|September 16, 2024
概括
矿物质皮质类受体对抗剂 (MRAs) 在心力衰竭中具有保存的喷射分数 (HFpEF) 和轻微减少的喷射分数 (HFmrEF) 的有效性正在被调查. 这项实用性试验使用注册数据来评估HFpEF/HFmrEF患者的MRA.
科学领域:
- 心脏病学 心脏病学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 矿物质皮质类受体抗剂 (MRAs) 在心力衰竭中具有保存和轻微减少的喷射分数 (HFpEF/HFmrEF) 的益处仍然未确立.
- 传统的HFpEF/HFmrEF随机对照试验复杂且昂贵.
- 在心力衰竭随机干预试验与保存的喷射小部分 (SPIRRIT-HFpEF) 提供了一个独特的务实,基于注册的方法.
研究的目的:
- 评估MRA在患有HFpEF/HFmrEF的患者中的有效性.
- 评估实用性,基于注册的随机对照试验在心力衰竭管理中的可行性.
- 为了确定螺旋和或eplerenone对心血管结果的影响,在这个患者群体.
主要方法:
- 一个多中心,前性,随机化,开放标签,盲目的终点试验,在瑞典心力衰竭注册表 (SwedeHF) 和美国试验创新网络平台上进行.
- 患有HFpEF/HFmrEF的患者随机分为1:1接受常规护理加上MRA (螺旋或烯) 与单独接受常规护理.
- 主要结局:心血管死亡和心力衰竭住院病例的组合,结局根据注册数据和美国呼叫中心进行判断.
主要成果:
- 数据收集正在进行中; 结果正在等待.
- 该试验旨在在六年内招募大约2400名患者.
- 资格标准是基于易于获得的注册数据,包括LVEF≥40%和特定NT-proBNP水平.
结论:
- 预计SPIRRIT-HFpEF将在HFpEF和HFmrEF中提供关于通用MRAs在HFpEF和HFmrEF有效性的关键信息.
- 该研究将证明实用性和基于注册的试验方法在心力衰竭和其他慢性疾病中的可行性.
- 这些发现将为管理HFpEF/HFmrEF的临床实践指南提供信息.
关键词:
阿尔多氨酸是一种阿尔多氨酸.埃普莱伦龙是一种Eplerenone.心脏衰竭与轻微减少的射出分数.心力衰竭与保存的喷射分数的心脏衰竭矿物甲类皮质体受体对手实用性试验试验实用性试验试验基于注册表的随机临床试验.螺旋乳是一种螺旋乳.更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
1.1K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
01:26Heart Failure Drugs: Inotropic Agents
543
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
543
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:22Heart Failure Drugs: β-Blockers
321
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
321
01:22Heart Failure Drugs: Diuretics
350
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
350